Form 4: AbbVie Executive Scott T. Reents Reports Stock Transaction
SEC Form 4 Filing
EVP and CFO of AbbVie, Scott T. Reents, reports disposition of shares to cover tax obligations.
Summary
- On February 28, 2025, Scott T. Reents, the EVP and Chief Financial Officer of AbbVie Inc., reported a transaction involving the company's common stock.
- Reents disposed of 10,973 shares of common stock at a price of $205.02 per share to cover tax obligations.
- Following the transaction, Reents directly owns 29,221 shares of AbbVie common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction for tax purposes.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock transaction |
| 03/04/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.